Candriam S.C.A. - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 157 filers reported holding MERSANA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$7,946,920
-29.1%
2,415,477
-18.5%
0.06%
-26.9%
Q1 2023$11,208,385
-29.0%
2,962,848
+10.0%
0.08%
-26.4%
Q4 2022$15,779,351
-6.6%
2,692,848
+7.8%
0.11%
-10.9%
Q3 2022$16,886,000
+83.6%
2,497,848
+25.5%
0.12%
+56.6%
Q2 2022$9,196,000
+24.9%
1,990,559
+7.9%
0.08%
+52.0%
Q1 2022$7,360,000
-41.5%
1,844,823
-8.8%
0.05%
-37.5%
Q4 2021$12,582,000
-34.0%
2,022,8950.0%0.08%
-38.5%
Q3 2021$19,075,000
-28.8%
2,022,895
+2.5%
0.13%
-29.0%
Q2 2021$26,792,000
-6.6%
1,972,895
+75.8%
0.18%
-23.4%
Q1 2021$28,682,000
-3.9%
1,122,173
+0.0%
0.24%
+1.3%
Q4 2020$29,861,000
+172.9%
1,122,145
+90.9%
0.24%
+129.1%
Q3 2020$10,943,000
-21.5%
587,708
-1.3%
0.10%
-29.9%
Q2 2020$13,941,000
+2354.4%
595,743
+1554.8%
0.15%
+1370.0%
Q1 2018$568,000
+188.3%
36,000
+200.0%
0.01%
+233.3%
Q4 2017$197,00012,0000.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
View complete list of MERSANA THERAPEUTICS INC shareholders